1 Non-oncology Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of Non-oncology Biopharmaceuticals
1.2 Classification of Non-oncology Biopharmaceuticals by Types
1.2.1 Global Non-oncology Biopharmaceuticals Revenue Comparison by Types (2020-2025)
1.2.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Types in 2018
1.2.3 Biologics
1.2.4 Biosimilars
1.3 Global Non-oncology Biopharmaceuticals Market by Application
1.3.1 Global Non-oncology Biopharmaceuticals Market Size and Market Share Comparison by Applications (2015-2025)
1.3.2 Immunology
1.3.3 Endocrinology
1.3.4 Others
1.4 Global Non-oncology Biopharmaceuticals Market by Regions
1.4.1 Global Non-oncology Biopharmaceuticals Market Size (Million USD) Comparison by Regions (2015-2025)
1.4.1 North America (USA, Canada and Mexico) Non-oncology Biopharmaceuticals Status and Prospect (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-oncology Biopharmaceuticals Status and Prospect (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-oncology Biopharmaceuticals Status and Prospect (2015-2025)
1.4.4 South America (Brazil, Argentina, Colombia) Non-oncology Biopharmaceuticals Status and Prospect (2015-2025)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-oncology Biopharmaceuticals Status and Prospect (2015-2025)
1.5 Global Market Size of Non-oncology Biopharmaceuticals (2015-2025)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Non-oncology Biopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Non-oncology Biopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Non-oncology Biopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Non-oncology Biopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.5 Novo Nordisk
2.5.1 Business Overview
2.5.2 Non-oncology Biopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Non-oncology Biopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.7 Merck
2.7.1 Business Overview
2.7.2 Non-oncology Biopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.8 Teva
2.8.1 Business Overview
2.8.2 Non-oncology Biopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Non-oncology Biopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.10 Bristol-Myers Squibb
2.10.1 Business Overview
2.10.2 Non-oncology Biopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Non-oncology Biopharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.12 UCB Pharma
2.12.1 Business Overview
2.12.2 Non-oncology Biopharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.13 Amgen
2.13.1 Business Overview
2.13.2 Non-oncology Biopharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.14 AbbVie
2.14.1 Business Overview
2.14.2 Non-oncology Biopharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.15 Takeda
2.15.1 Business Overview
2.15.2 Non-oncology Biopharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.16 AstraZeneca
2.16.1 Business Overview
2.16.2 Non-oncology Biopharmaceuticals Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.17 Mylan
2.17.1 Business Overview
2.17.2 Non-oncology Biopharmaceuticals Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.18 LEO Pharma
2.18.1 Business Overview
2.18.2 Non-oncology Biopharmaceuticals Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.19 Boehringer Ingelheim
2.19.1 Business Overview
2.19.2 Non-oncology Biopharmaceuticals Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.20 Alexion Pharmaceuticals
2.20.1 Business Overview
2.20.2 Non-oncology Biopharmaceuticals Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.21 Elusys Therapeutics
2.21.1 Business Overview
2.2.2 Non-oncology Biopharmaceuticals Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.22 Swedish Orphan Biovitrum
2.22.1 Business Overview
2.22.2 Non-oncology Biopharmaceuticals Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
2.23 Biogen
2.23.1 Business Overview
2.23.2 Non-oncology Biopharmaceuticals Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2019)
3 Global Non-oncology Biopharmaceuticals Market Competition, by Players
3.1 Global Non-oncology Biopharmaceuticals Revenue and Share by Players (2015-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-oncology Biopharmaceuticals Players Market Share
3.2.2 Top 10 Non-oncology Biopharmaceuticals Players Market Share
3.3 Market Competition Trend
4 Global Non-oncology Biopharmaceuticals Market Size by Regions
4.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Regions
4.2 North America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
4.3 Europe Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
4.4 Asia-Pacific Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
4.5 South America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
4.6 Middle East and Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
5 North America Non-oncology Biopharmaceuticals Revenue by Countries
5.1 North America Non-oncology Biopharmaceuticals Revenue by Countries (2015-2019)
5.2 USA Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
5.3 Canada Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
5.4 Mexico Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
6 Europe Non-oncology Biopharmaceuticals Revenue by Countries
6.1 Europe Non-oncology Biopharmaceuticals Revenue by Countries (2015-2019)
6.2 Germany Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
6.3 UK Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
6.4 France Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
6.5 Russia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
6.6 Italy Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
7 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries
7.1 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries (2015-2019)
7.2 China Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
7.3 Japan Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
7.4 Korea Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
7.5 India Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
7.6 Southeast Asia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
8 South America Non-oncology Biopharmaceuticals Revenue by Countries
8.1 South America Non-oncology Biopharmaceuticals Revenue by Countries (2015-2019)
8.2 Brazil Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
8.3 Argentina Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
8.4 Colombia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
9 Middle East and Africa Revenue Non-oncology Biopharmaceuticals by Countries
9.1 Middle East and Africa Non-oncology Biopharmaceuticals Revenue by Countries (2015-2019)
9.2 Saudi Arabia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
9.3 UAE Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
9.4 Egypt Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
9.5 Nigeria Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
9.6 South Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2015-2019)
10 Global Non-oncology Biopharmaceuticals Market Segment by Type
10.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Type (2015-2019)
10.2 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2020-2025)
10.3 Biologics Revenue Growth Rate (2015-2025)
10.4 Biosimilars Revenue Growth Rate (2015-2025)
11 Global Non-oncology Biopharmaceuticals Market Segment by Application
11.1 Global Non-oncology Biopharmaceuticals Revenue Market Share by Application (2015-2019)
11.2 Non-oncology Biopharmaceuticals Market Forecast by Application (2020-2025)
11.3 Immunology Revenue Growth (2015-2019)
11.4 Endocrinology Revenue Growth (2015-2019)
11.5 Others Revenue Growth (2015-2019)
12 Global Non-oncology Biopharmaceuticals Market Size Forecast (2020-2025)
12.1 Global Non-oncology Biopharmaceuticals Market Size Forecast (2020-2025)
12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Regions (2020-2025)
12.3 North America Non-oncology Biopharmaceuticals Revenue Market Forecast (2020-2025)
12.4 Europe Non-oncology Biopharmaceuticals Revenue Market Forecast (2020-2025)
12.5 Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Forecast (2020-2025)
12.6 South America Non-oncology Biopharmaceuticals Revenue Market Forecast (2020-2025)
12.7 Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Forecast (2020-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
